Portfolio (Quarterly)
Guide ↗
Fairmount Funds Management LLC
· CIK 0001802528| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | COGT | COGENT BIOSCIENCES INC | Healthcare | 9,003,418.0 | $319.8M | 24.34% | NEW | — | $35.52 | -9.0% |
| 2 | — | APOGEE THERAPEUTICS INC | — | 2,048,647.0 | $154.6M | 11.77% | NEW | — | $75.48 | — |
| 3 | SYRE | SPYRE THERAPEUTICS INC | Healthcare | 4,018,101.0 | $131.6M | 10.02% | NEW | — | $32.76 | +161.6% |
| 4 | VRDN | VIRIDIAN THERAPEUTICS INC | Healthcare | 3,914,458.0 | $121.8M | 9.27% | NEW | — | $31.12 | -34.2% |
| 5 | ORKA | ORUKA THERAPEUTICS INC | Healthcare | 3,705,262.0 | $112.3M | 8.55% | NEW | — | $30.31 | +178.7% |
| 6 | DNTH | DIANTHUS THERAPEUTICS INC | Healthcare | 2,137,191.0 | $88.1M | 6.70% | NEW | — | $41.21 | +114.9% |
| 7 | ZBIO | ZENAS BIOPHARMA INC | Healthcare | 2,209,025.0 | $80.2M | 6.11% | NEW | — | $36.31 | -25.8% |
| 8 | NUVL | NUVALENT INC | Healthcare | 727,563.0 | $73.2M | 5.57% | NEW | — | $100.59 | +23.2% |
| 9 | JBIO | JADE BIOSCIENCES INC | Healthcare | 4,553,494.0 | $70.3M | 5.35% | NEW | — | $15.43 | -6.5% |
| 10 | ELVN | ENLIVEN THERAPEUTICS INC | Healthcare | 3,711,444.0 | $57.2M | 4.35% | NEW | — | $15.40 | +190.6% |
| 11 | — | KINIKSA PHARMACEUTICALS INTL | — | 1,319,688.0 | $54.4M | 4.14% | NEW | — | $41.25 | — |
| 12 | — | CRESCENT BIOPHARMA INC. | — | 2,747,866.0 | $32.6M | 2.48% | NEW | — | $11.86 | — |
| 13 | — | INHIBIKASE THERAPEUTICS INC | — | 8,625,000.0 | $17.7M | 1.35% | NEW | — | $2.05 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%